Educational information, not medical advice — ask your doctor or midwife.
Guayusa is a holly tree native to the upper Amazon basin, particularly Ecuador, Peru, and Colombia, where Indigenous Kichwa communities have brewed its leaves as a morning ritual tea for generations. Unlike many herbal teas, it contains a meaningful amount of caffeine — similar to green tea or slightly more — but paired with L-theanine and theobromine, which soften the stimulant effect and promote a calm, focused alertness. It has a naturally smooth, slightly sweet flavor with no bitterness, making it one of the most approachable caffeinated botanicals.
The caffeine in guayusa blocks adenosine receptors in the brain, reducing feelings of fatigue and sharpening focus. L-theanine promotes relaxed alertness by supporting alpha brain wave activity, working with caffeine to deliver energy without the crash or anxiety that coffee can trigger. Theobromine adds a mild, longer-lasting stimulant effect and gentle mood lift, while a rich polyphenol profile helps protect cells from oxidative stress.
Loose-leaf and tea bag forms are the most traditional and widely available, typically steeped for 5–7 minutes. Powdered guayusa can be mixed into smoothies or drinks. Capsule and extract formats are available for standardized dosing. Several commercial energy drinks now use guayusa as a cleaner caffeine source.
The Kichwa people of Ecuador have brewed guayusa as a pre-dawn ritual for centuries, using it before hunts and ceremonial gatherings. It is intertwined with storytelling and community connection in Amazonian culture. Unlike yerba mate or green tea, guayusa has only recently been introduced to Western markets, with commercial cultivation expanding in Ecuador from the early 2010s onward.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.